✨ Exciting Updates from  ✨ In 2024, we saw fantastic growth and engagement across the board with our platform: Traffic on the rise: More visitors than ever are exploring our platform, with steady increases in visits, page views, and time spent on site. Global and local reach: We're making a stronger impact worldwide, with a noticeable boost in impressions and clicks - especially from Ireland, highlighting our local relevance! Engaged users: Visitors are actively engaging with our resources, demonstrating the value we provide to HCPs and patients. Thank you to everyone who has contributed to this success - we're proud to continue serving you! 🚀

The team at IPHA would like to wish all of our valued Members, Affiliates and Stakeholders a very happy and peaceful Christmas. Please note, the IPHA offices will be closed from lunchtime on Tuesday, December 24th and will re-open on Thursday, January 2nd.

Here at IPHA, we are delighted to share the highlight reel from our final IPHA Forum of 2024 which took place last week and looked at how AI is impacting patient outcomes on a practical level. Sponsored by our IPHA Affiliate members EY, this fascinating discussion was expertly moderated by Johanna McLoughlin (Head of Life Sciences at EY). We also heard fascinating insights from Donal O'Shea (CEO at Deciphex), Mary Coghlan (Partner in Data, Analytics & AI @ EY) and Dr Guido Giunti (Therapeutic Lead at Trinity College Dublin). To listen back to the webinar in full, please click here

Jen’s special day was unforgettable as she experienced it migraine-free. Discover how she overcame it. To listen to this podcast, please select your preferred option at this link #LifeBecauseOfNewMedicines

🚀 Introducing SPCcomply to the suite of services! 🚀 IPHA are delighted to offer a new cutting-edge digital service designed for biopharmaceutical companies to keep their teams up-to-date with the latest SPCs at all times. With SPCcomply, your team benefits from: - In-app and email notifications for instant updates on mobile devices - An intuitive dashboard that tracks user activity upon acknowledgment of updates on - Simplified internal processes and SOPs, enhancing remote management - Optimized inspection readiness with exportable data for compliance Stay compliant, stay informed, and stay ahead with SPCcomply! Register today.

Last chance to register! Join us tomorrow to hear our panel of experts explore how AI is transforming healthcare. Hear from industry experts like Dr Guido Giunti, Therapeutic Lead at Trinity College, Dublin who will talk about some amazing projects that he is working on in this area that are aimed at helping to improve the lives of patients. Don’t miss it. Sign up here

Last chance to register! Join us tomorrow to hear our panel of experts explore how AI is transforming healthcare. Hear from industry experts like Donal O' Shea, Chief Executive of Deciphex who will talk about some amazing projects that his company are working on including a project with Novartis Ireland that will help improve the lives of patients everywhere. Don’t miss it. Sign up here

IPHA would like to congratulate Sharon Cunningham and Orlaith Ryan of Tipperary-based Shorla Oncology who have been named the 2024 EY Entrepreneurs of the Year. Shorla Oncology develop and commercialise innovative oncology drugs for orphan and paediatric cancers, and the company's mission is to make existing oncology treatments better through formulation re-innovation. It is inspiring to see these types of innovative products being developed in Ireland and such innovation should be strongly encouraged and supported. It is important however that we create the right IP and policy environment to support innovation within this sector which is so vital to our economy.

Its Election Day 2024! Now its time for the electorate to have their say. Health has been a key issue in this general election and we need to see sustained improvements across a range of areas. Here at IPHA we were happy that many of the parties incorporated our ideas about how to improve speed of access for patients to new life-enhancing medicines. These proposals include a stronger voice for doctors, early access schemes, more clinical trials and faster access to orphan medicines. There appears to be no political disagreement that we need faster access to medicines, the only difference now is just how much it is emphasised across parties. Once the election is over and it comes time to negotiate a Programme for Government, parties must put practical policies, as already outlined in their manifestos, into the Programme. Crucially, they also must follow up quickly once in Government to make sure they are implemented. This will ensure a continuous flow of new medicines and vaccines to patients in Ireland. Industry is ready to play its part with the next Government to ensure this happens and we are looking forward to working with the next government. Here is snapshot of which parties incorporated into their manifestos the three IPHA asks which call for the Right Medicine, at the Right Time.

Tomorrow November 29th, Ireland will go to the polls. At IPHA we want to ensure that all patients in Ireland have the chance to live their lives to the full and create new memories. That is why we are calling for the next government to sign up to a #NewMedicinesPledge to ensure patients in Ireland have faster and fairer access to life-enhancing medicines and vaccines. Simon Harris Micheál Martin Stephen Donnelly Jack Chambers Helen McEntee

Eimear Caslin from GSK Ireland explains why all stakeholders need to come together, partnering with industry, to ensure that a #NewMedicinesPledge can be adopted by the next Government. To hear her full account and to understand why IPHA is asking for a new voice for doctors in prioritising new medicines for patient, for the doubling of the number of clinical trials in Ireland and faster access to medicines for patients with rare diseases, watch the IPHA Forum event here

Now that political party manifestos have been published, and we understand that there is broad consensus among all political parties that there is a need for faster access to medicines for patients in Ireland, Lucinda Creighton explains what we need to do now to ensure reform under the next Government. To hear her full account and why candidates need to be hearing about these issues on the doorstep, watch the full IPHA Forum event by clicking here

How is AI positively impacting the lives of patients and how is it currently being used? Join us for our final IPHA Forum webinar for 2024 when Johanna Mc Loughlin, Partner & Head of Life Sciences at EY will moderate a panel discussion on How AI is Improving Patient Lives and Healthcare Delivery. This event will take place on Wednesday December 4th from 12-1 so please join us as we explore the impact of AI on treatment precision, accessibility, and patient outcomes, with insights from experts in the field. Register here

Vicky Mc Grath, CEO of Rare Diseases Ireland sees no reason why Ireland shouldn’t become the ‘go to’ location for clinical trials and a country where patients get speedy access to new life-enhancing medicines. To view this discussion in full, go to #NewMedicinesPledge

When oncologist Austin Duffy returned to Ireland from working overseas, he was amazed to find that Irish clinicians did not have a voice in deciding which medicines should be available for their patients. To hear his full account and why he agrees with the IPHA ask for a new voice for doctors in prioritising new medicines, watch the IPHA Forum event here

More clinical trials for Irish patients. For many patients, clinical trials are their only option. Medical director Orlaith talks about the importance in Ireland. #LifeBecauseOfNewMedicines To listen to this podcast in full or follow our campaign, click here

Delighted to share this highlight reel from last weeks’ IPHA Forum on why the next Government needs to commit to a #NewMedicinesPledge. During this event, the panel discussed why Irish patients need timely access to the right medicines, a doubling of the number of clinical trials and faster treatment for patients with rare diseases. Huge thanks to Lucinda Creighton of Vulcan Consulting for moderating and to our panelists, Eimear Caslin, Vicky McGrath and Ausin Duffy. This event was sponsored by Vulcan Consulting. Missed this fascinating discussion? Don't worry, you can catch up by watching the playback here 

Living with type 1 diabetes. New diabetes medicines gave Carmel back her freedom. Let’s give everyone access to the diabetes medicines they need. hashtag#LifeBecauseOfNewMedicines To listen to our podcast or find out more about this campaign, click here

RT @aesgp: Regulation can ensure trusted information and products are available, and providers can be leaders in supporting people when and…